- Previous Close
1.0000 - Open
0.9920 - Bid 1.0000 x --
- Ask 1.0500 x --
- Day's Range
0.9920 - 1.0500 - 52 Week Range
0.8510 - 5.1000 - Volume
1,367,936 - Avg. Volume
2,226,919 - Market Cap (intraday)
12.681M - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Jun 26, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.83
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
polarean.comRecent News: POLX.L
View MorePerformance Overview: POLX.L
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: POLX.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: POLX.L
View MoreValuation Measures
Market Cap
12.07M
Enterprise Value
680.28k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.03
Price/Book (mrq)
1.01
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-32.28%
Return on Equity (ttm)
-60.59%
Revenue (ttm)
1.87M
Net Income Avi to Common (ttm)
-8.55M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
15.22M
Total Debt/Equity (mrq)
0.93%
Levered Free Cash Flow (ttm)
-2.84M